MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-02-2026
Quanterix Corporation Total Liabilities 2011-2026 | QTRX
Annual Total Liabilities Quanterix Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123 M | 76.5 M | 78.1 M | 75.3 M | 60.6 M | 64.9 M | 41.3 M | 26.5 M | 25.9 M | 23.6 M | 22.5 M | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 123 M | 22.5 M | 56.2 M |
Quarterly Total Liabilities Quanterix Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 130 M | 83.2 M | 80.1 M | 76.5 M | - | 74.5 M | 70.3 M | 78.1 M | 73.9 M | 70 M | 75.3 M | 73.9 M | - | - | 60.6 M | 55.3 M | 62 M | 61.2 M | 64.9 M | 64.9 M | 64.9 M | 64.9 M | 41.3 M | 41.3 M | 41.3 M | 41.3 M | 26.5 M | 26.5 M | 26.5 M | 26.5 M | 25.9 M | 25.9 M | 25.9 M | 25.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 130 M | 25.9 M | 56.7 M |
Total Liabilities of other stocks in the Medical devices industry
| Issuer | Total Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
BioSig Technologies
BSGM
|
2.26 M | - | 37.08 % | $ 85.7 M |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
129 M | - | - | $ 1.77 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
89.2 M | - | - | $ 3.31 B | USA |
 |
Xtant Medical Holdings
XTNT
|
50.9 M | $ 0.55 | -2.31 % | $ 73.5 M | USA |
 |
Dynatronics Corporation
DYNT
|
12.2 M | - | 14.99 % | $ 929 K | USA |
 |
Aziyo Biologics
AZYO
|
34.7 M | - | 1.37 % | $ 20.5 M | USA |
 |
Acutus Medical
AFIB
|
54.8 M | - | -26.83 % | $ 2.62 M | USA |
 |
Zimmer Biomet Holdings
ZBH
|
8.89 B | $ 88.57 | -0.65 % | $ 18 B | USA |
 |
Allied Healthcare Products
AHPI
|
3.56 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
5.95 M | - | -5.86 % | $ 30.6 M | USA |
 |
Alphatec Holdings
ATEC
|
126 M | $ 10.93 | -5.12 % | $ 1.64 B | USA |
 |
Conformis
CFMS
|
39.9 M | - | - | $ 16.4 M | USA |
 |
Accuray Incorporated
ARAY
|
389 M | $ 0.4 | 4.21 % | $ 41.1 M | USA |
 |
Cardiovascular Systems
CSII
|
73.2 M | - | 0.15 % | $ 844 M | USA |
 |
Second Sight Medical Products
EYES
|
23.7 M | - | -0.97 % | $ 54.4 M | USA |
 |
Apollo Endosurgery
APEN
|
77.6 M | - | - | $ 475 M | USA |
 |
Avinger
AVGR
|
20 M | - | -20.74 % | $ 369 K | USA |
 |
CryoLife, Inc.
CRY
|
461 M | - | -4.14 % | $ 702 M | USA |
 |
CONMED Corporation
CNMD
|
1.29 B | $ 34.58 | -5.62 % | $ 1.07 B | USA |
 |
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.44 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
21.1 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
NanoVibronix
NAOV
|
3 M | - | - | $ 1.08 M | USA |
 |
Misonix, Inc.
MSON
|
57.2 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
14 M | - | - | $ 111 M |  Canada |
 |
Intersect ENT, Inc.
XENT
|
160 M | - | - | $ 955 M | USA |
 |
Cytosorbents Corporation
CTSO
|
36.3 M | $ 0.59 | -1.18 % | $ 32.1 M | USA |
 |
Aethlon Medical
AEMD
|
2.24 M | $ 2.15 | -5.29 % | $ 3.36 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
3.36 B | $ 79.34 | -3.36 % | $ 46.4 B | USA |
 |
BIOLASE
BIOL
|
33.1 M | - | -13.19 % | $ 166 K | USA |
 |
AdaptHealth Corp.
AHCO
|
2.79 B | $ 11.2 | -1.84 % | $ 1.51 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
162 M | $ 15.52 | -5.08 % | $ 364 M | USA |
 |
Invacare Corporation
IVC
|
544 M | - | - | $ 24.7 M | USA |
 |
Ra Medical Systems
RMED
|
7.58 M | - | 10.0 % | $ 610 K | USA |
 |
Myomo
MYO
|
27.2 M | $ 0.7 | 2.32 % | $ 29.3 M | USA |
 |
Penumbra
PEN
|
399 M | $ 335.1 | -0.39 % | $ 13 B | USA |
 |
Inspire Medical Systems
INSP
|
126 M | $ 50.13 | -0.63 % | $ 1.47 B | USA |
 |
Pulmonx Corporation
LUNG
|
75.2 M | $ 1.17 | -5.65 % | $ 47.6 M | USA |
 |
Cutera
CUTR
|
518 M | - | -10.19 % | $ 1.99 M | USA |
 |
Eargo
EAR
|
31.2 M | - | - | $ 10.2 M | USA |
 |
NuVasive
NUVA
|
970 M | - | - | $ 2.07 B | USA |
 |
Nevro Corp.
NVRO
|
323 M | - | - | $ 217 M | USA |
 |
Surgalign Holdings
SRGA
|
86 M | - | -32.98 % | $ 1.68 M | USA |
 |
STRATA Skin Sciences
SSKN
|
30.4 M | - | - | $ 6.6 M | USA |
 |
GBS
GBS
|
5.44 M | - | -0.57 % | $ 7.12 M | USA |
 |
AVITA Medical
RCEL
|
73 M | $ 3.82 | -1.04 % | $ 106 M |  Australia |
 |
AxoGen
AXGN
|
92.8 M | $ 31.28 | -3.01 % | $ 1.44 B | USA |
 |
Delcath Systems
DCTH
|
12.4 M | $ 8.97 | -1.75 % | $ 321 M | USA |